Literature DB >> 15657684

[Desmoid-type fibromatosis (aggressive fibromatosis)].

C Kuhnen1, M Helwing, S Rabstein, H-H Homann, K-M Müller.   

Abstract

Desmoid-type fibromatoses (aggressive fibromatoses) represent infiltrative, locally destructively growing soft tissue tumors with a high potential for recurrence. Desmoid tumors of 33 adult patients were analysed regarding clinical and morphological aspects (sex, age distribution, site, size, mitotic rate, tumor microvessel density, surgical margins, additional radiotherapy). Possible statistical correlations were examined using log-rank-tests. No prognostic significance of tumor microvessel density was evident. A correlation between mitotic index (1 or more mitoses per 50 high power fields) and local relapse rate was notably striking, but not statistically significant (log-rank: 0.17). Additional postoperatively applied radiotherapy proved to be statistically significant to avoid local recurrences (log-rank: 0.01). The presented results may indicate an increased risk for local relapse in those desmoid-type fibromatoses which are mitotically active. Postoperative radiotherapy seems to be effective in the treatment of aggressive fibromatosis to avoid tumor recurrence. Differential diagnosis of desmoid-type fibromatosis/aggressive fibromatosis in adulthood include various fibroblastic/myofibroblastic soft tissue tumors such as nodular fasciitis, fibrosarcoma, low-grade fibromyxoid sarcoma, myofibroblastic sarcoma as well as leiomyosarcoma and soft tissue leiomyoma.

Entities:  

Mesh:

Year:  2005        PMID: 15657684     DOI: 10.1007/s00292-004-0742-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  15 in total

1.  Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas.

Authors:  A L Folpe; K L Lane; G Paull; S W Weiss
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Radiation therapy for aggressive fibromatosis. The Experience at the University of Florida.

Authors:  W M McCollough; J T Parsons; R van der Griend; W F Enneking; T Heare
Journal:  J Bone Joint Surg Am       Date:  1991-06       Impact factor: 5.284

3.  Infantile desmoid-type fibromatosis. Morphological features correlate with biological behaviour.

Authors:  D Schmidt; P Klinge; I Leuschner; D Harms
Journal:  J Pathol       Date:  1991-08       Impact factor: 7.996

Review 4.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.

Authors:  P B Vermeulen; G Gasparini; S B Fox; M Toi; L Martin; P McCulloch; F Pezzella; G Viale; N Weidner; A L Harris; L Y Dirix
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

Review 5.  Myofibroblastic tumours: an update.

Authors:  C D Fletcher
Journal:  Verh Dtsch Ges Pathol       Date:  1998

6.  Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid). Analysis of thirty cases followed up for ten or more years.

Authors:  F M Enzinger; M Shiraki
Journal:  Cancer       Date:  1967-07       Impact factor: 6.860

7.  Fibromatoses: clinical and pathological features suggestive of recurrence.

Authors:  J Baerg; J J Murphy; J F Magee
Journal:  J Pediatr Surg       Date:  1999-07       Impact factor: 2.545

8.  [Desmoid tumors and their mitotic system (morphological diagnosis and problems of prognosis)].

Authors:  I G Ol'khovskaia; I A Kazantseva
Journal:  Arkh Patol       Date:  1976

9.  Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy.

Authors:  J T Plukker; I van Oort; A Vermey; I Molenaar; H J Hoekstra; A K Panders; W V Dolsma; H S Koops
Journal:  Br J Surg       Date:  1995-04       Impact factor: 6.939

Review 10.  [Myofibroblastic tumors. Brief review of clinical aspects, diagnosis and differential diagnosis].

Authors:  T Mentzel; D Katenkamp
Journal:  Pathologe       Date:  1998-05       Impact factor: 1.011

View more
  7 in total

1.  [Intramuscular nodular fasciitis--a clinicopathological study with emphasis on myogenic giant cells].

Authors:  T Hansen; K Katenkamp; D Katenkamp
Journal:  Pathologe       Date:  2006-05       Impact factor: 1.011

2.  [Huge retrovesical tumor as an incidental finding: desmoid-type fibromatosis: a case report].

Authors:  T Franz; T Häfner; L C Horn; W Kassahun; J-U Stolzenburg
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

3.  Role of tumor-associated macrophages and angiogenesis in desmoid-type fibromatosis.

Authors:  Stefhanie Romero; Justyna Szafranska; Eliovel Cabrera; Allan Gonzalez; Ana Peiró; Jaume Llauger; Luis Ortega; Silvia Bague; Belén Canet; Inigo Espinosa; Jaime Prat
Journal:  Virchows Arch       Date:  2012-06-29       Impact factor: 4.064

4.  [Aggressive fibromatosis (desmoid tumor) : A rare differential diagnosis of metastasis of renal cell carcinoma].

Authors:  A Janitzky; M Porsch; M Daher; D Küster; U-B Liehr
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

5.  [Gardner fibroma: case report and discussion of a new soft tissue tumor entity].

Authors:  C Lanckohr; M Debiec-Rychter; O Müller; H-H Homann; M Lehnhardt; P Herter; C Kuhnen
Journal:  Pathologe       Date:  2010-03       Impact factor: 1.011

6.  Diagnosis and treatment of extraabdominal desmoid fibromatosis.

Authors:  Mohamed Ghanem; Antje Heinisch; Christoph-E Heyde; Georg Freiherr von Salis-Soglio
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2014-02-24

7.  Value of imaging findings in predicting post-operative recurrence of desmoid-type fibromatosis.

Authors:  Junyan Wang; Yijuan Huang; Yanbao Sun; Yuxi Ge; Minming Zhang
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.